$CGC news
The latest CGC stock news: headlines, filings, AI summaries and sentiment for $CGC, updated around the clock.
- Canopy Growth Reports Q2 Fiscal 2027 Revenue Growth and International Expansion Progress
- PSA Dominates Trading Card Grading Market as Collectors Treat Cards as Alternative Investments
- Canopy Growth Targets Increased Flower Output in Kincardine and Positive EBITDA by H2 FY2027
- Canopy Growth Reports 22% Revenue Growth Driven by International Expansion and MTL Cannabis Acquisition
- Canopy Growth Reports 22% Year-over-Year Revenue Growth in Q2 FY27
- Canopy Growth Corp - 8-K Filing
- Canopy Growth Corp - 10-Q Filing
- Key Corporate Earnings Reports Scheduled for Friday Pre-Market
- Canopy Growth Scheduled to Report Q2 Fiscal 2027 Earnings on November 6
- Comparative Revenue Analysis of Canopy Growth and Tilray Brands
- Trump's Marijuana Rescheduling Order Faces Delays at DEA, Impacting Canopy Growth
- Canopy Growth Corp - 8-K Filing
- Canopy Growth Approaching Positive EBITDA Amid Revenue Growth
- Canopy Growth Announces Medical Cannabis Supply Deal in the United Kingdom
- Canopy Growth Considers Another Reverse Stock Split Amid Falling Share Price
- Canopy Growth Enters UK Medical Cannabis Market Through Partnership with GROW Group
- Canopy Growth Reports Improved Financials Despite Stock Struggles
- Canopy Growth Reports Improved Financials Despite Weak Stock Performance
- Canopy Growth Reports 13% Year-Over-Year Revenue Increase, But Stock Reaction Remains Muted
- Canopy Growth Reports 13% Revenue Increase, but Investors Remain Skeptical
- Investors Should Consider Waiting for DEA Rescheduling Decision Before Buying Canopy Growth
- President Trump Reschedules Marijuana to Schedule III: Impact on Canopy Growth, Green Thumb, and Tilray
- Trump Executive Order Reschedules Medical Marijuana; Impact on Cannabis Companies
- Aurora Cannabis Reports Strong FY26 Performance with Medical Sales Growth
- Canopy Growth Acquires MTL Cannabis for $125 Million
- Canopy Growth Acquires MTL Cannabis for $125 Million to Strengthen Market Position
- Canopy Growth Shows Early Signs of Turnaround Despite Continued Challenges
- DEA Reschedules Marijuana to Schedule III; Implications for Canopy Growth
- Canopy Growth Corp Expands Medical Product Line with New Pack Sizes
- Canopy Growth Announces Restatement of Two Years' Financials Ahead of June Earnings
- Canopy Growth Announces Restatement of Two Years' Financial Results Ahead of Earnings
- Canopy Growth Corp - 8-K Filing
- Canopy Growth Stock Rises Amid Marijuana Rescheduling News
- Marijuana Reclassified from Schedule I to Schedule III, Impact on Cannabis Stocks
- Tilray Brands Struggles Despite Legal Cannabis Market in Canada
- Canopy Growth Launches New Cannabis Product Line and Completes Acquisition